New treatments in amyotrophic lateral sclerosis

Neuropsychopharmacology

Volumn 36, Issue 1, 2011, Pages 370-372

  Maragakis, Nicholas ^a   Rothstein, Jeffrey D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; COPPER ZINC SUPEROXIDE DISMUTASE; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; SUPEROXIDE DISMUTASE; TAR DNA BINDING PROTEIN; TRANSCRIPTION FACTOR SOX2;

AMYOTROPHIC LATERAL SCLEROSIS; ANTISENSE THERAPY; CEREBROSPINAL FLUID; CLINICAL TRIAL; DISEASE COURSE; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ELECTROPHYSIOLOGY; FIBROBLAST; FRONTOTEMPORAL DEMENTIA; GENE IDENTIFICATION; GENE MUTATION; HUMAN; MOTOR NEURON DISEASE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA INTERFERENCE; RNA METABOLISM; SHORT SURVEY; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION REGULATION; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; RNA-BINDING PROTEIN FUS; SUPEROXIDE DISMUTASE;

EID: 78649672510     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.140     Document Type: Short Survey

References (6)

1. Lagier-Tourenne C, Polymenidou M, Cleveland DW (2010). TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19: R46-R64.
2. Lin CL, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, Clawson L et al (1998). Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyo-trophic lateral sclerosis. Neuron 20: 589-602.
3. Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 106: 18809-18814.
4. Miller TM, Kaspar BK, Kops GJ, Yamanaka K, Christian LJ, Gage FH et al (2005). Virus-delivered small RNA silencing sustains strength in amyo-trophic lateral sclerosis. Ann Neurol 57: 773-776.
5. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
6. Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD et al (2008). Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 11: 1294-1301.